Document:

STOCK PURCHASE AGREEMENT

     This  STOCK  PURCHASE  AGREEMENT (this "Agreement") is made as of April 15,
2003  by  and  between NeoGenomics, Inc., a Nevada corporation, (the "Company"),
NeoGenomics,  Inc.,  a  Florida corporation and a wholly-owned subsidiary of the
Company (the "Subsidiary"), and Steven C. Jones, an individual (the "Investor").

     THE  PARTIES  HEREBY  AGREE  AS  FOLLOWS:

1.     Purchase  and  Sale  of  Stock.

          1.1     Sale  and  Issuance  of Common Stock.     Subject to the terms
                  ------------------------------------
and  conditions  of this Agreement, and in reliance upon the representations and
warranties  and  covenants  contained herein, the Investor agrees to purchase at
the  Closing,  and  the  Company agrees to sell and issue to the Investor at the
Closing  (as  defined  herein),  1,541,261 shares of the Company's Common Stock,
$.001  par  value  (the  "Common  Stock")  for  the  aggregate purchase price of
$15,412.61.

          1.2     Closing.  The purchase and sale of the Common Stock shall take
                  -------
place  at  the  offices of Membrado & Montell, LLP, New York, New York, at 10:00
A.M.,  on  April 15, 2003 or at such other time and place as the Company and the
Investor agree upon orally or in writing (which time and place are designated as
the  "Closing").  At  the  Closing,  the  Company  shall deliver to the Investor
certificates  (in  the denominations requested by the Investor) representing the
Common Stock which the Investor is purchasing against delivery to the Company by
the  Investor  of  the  full  purchase  price  therefor,  which shall be paid by
cashier's  or  bank  check payable to the Company's order or by wire transfer to
such  account  as  the  Company  shall  designate.

          1.3     Requirement  of  Purchase  Price Delivery.  No purchase of any
                  -----------------------------------------
shares of Common Stock hereof shall be deemed to have been made pursuant to this
Agreement  and no rights hereunder shall inure to the Investor, unless the total
purchase  price  for  the  Common  Stock is delivered at the Closing pursuant to
Section  1.2  hereof.

     2.     Representations  and Warranties of the Company.  The Company and the
            ----------------------------------------------
Subsidiary  hereby  represents  and  warrants  to  the  Investor  that:

          2.1     Organization  and  Good Standing.  Each of the Company and the
                  --------------------------------
Subsidiary  is  a  corporation  duly  organized,  validly  existing, and in good
standing  under  the  laws  of  its  state of organization and has all requisite
corporate  power  and authority to carry on its business as now conducted and as
proposed  to  be conducted.  Each of the Company and the Subsidiary is qualified
to  do  business  in  each  jurisdictions  where such qualification is required,
except  where  the  lack of such qualification would not have a material adverse
effect  on  the business or assets of the Company and the Subsidiary, taken as a
whole.

          2.2     Capitalization.    The  current  capitalization of the Company
                  --------------
is  as  follows:

               (a)     Common  Stock:  There  are  currently one hundred million
                       -------------
(100,000,000)  authorized  shares of Common Stock, par value $.001 per share, of
which  18,409,416  shares  are issued and outstanding after giving effect to the
transactions  contemplated  hereby.

               (b)     On  a  Fully-Diluted Basis:  Except for (i) 40,000 shares
                       --------------------------
which  the  Company  intends  to  issue  to Technology Capital Group, Inc., (ii)
20,000  shares  which  the  Company  intends to issue to its Scientific Advisory
Board,  and (iii) an option to acquire 100,000 shares at the market price on the
date of issuance, which the Company intends to issue to a member of its Board of
Directors,  there  are  not outstanding any options, warrants, rights (including
conversion  or preemptive rights), or agreements for the purchase or acquisition
from  the  Company  or, to the knowledge of the Company from any shareholder, of
any  shares  of  the  capital  stock  of  the  Company.

          2.3     Subsidiaries.  Except for the Subsidiary, the Company does not
                  ------------
presently  own  or  control,  directly  or indirectly, any interest in any other
corporation,  association,  or  other  business  entity.

          2.4     Authorization.  All  corporate  action  on  the  part  of  the
                  -------------
Company  and  the  Subsidiary,  and  their  respective  officers, directors, and
shareholders  necessary  for  the authorization, execution, and delivery of this
Agreement  and the agreements attached as exhibits hereto (such agreements being
herein  referred  to  as  the  "Ancillary  Agreements"),  the performance of all
obligations of the Company and/or the Subsidiary under each of the Agreement and
the  Ancillary  Agreements,  and the authorization, issuance (or reservation for
issuance),  and delivery of the Common Stock being sold hereunder has been taken
or  will  be  taken  prior  to the Closing, and this Agreement and the Ancillary
Agreements  constitute (or will constitute upon the execution thereof) the valid
and  legally  binding  obligations  of the Company and/or the Subsidiary, as the
case  may  be,  and each of the other parties thereto (other than the Investor),
enforceable  in  accordance  with  their  respective terms.  The Company and the
Subsidiary  has  the  requisite  corporate  power  to enter into and perform its
obligations  under  this  Agreement  and  the  Ancillary  Agreements.

           2.5     Valid  Issuance  of  Common  Stock.
                   ----------------------------------

                (a)     The  Common  Stock  which  is  being  purchased  by  the
Investor  hereunder,  when  issued,  sold,  and delivered in accordance with the
terms  hereof  or  thereof,  will  be  duly  and  validly issued, fully paid and
nonassessable  free  and clear of any taxes, liens, claims, preemptive rights or
similar  rights  or  encumbrances imposed by or through the Company or under law
and,  assuming  the  accuracy  of  the  representations  of the Investor in this
Agreement,  will  be issued in compliance with all applicable federal  and state
securities  laws.

               (b)     The  outstanding  shares of Common Stock are all duly and
validly  authorized and issued, fully paid and nonassessable, were not issued in
violation of the terms of any contract binding upon the Company, and were issued
in  compliance  with  all  applicable  federal  and  state  securities  laws.

          2.6     Governmental  Consents.  No  consent,  approval,  order,  or
                  ----------------------
authorization  of,  or registration, qualification, designation, declaration, or
filing  with, any federal, state, local, or provincial governmental authority on
the  part  of  the  Company or the Subsidiary is required in connection with the
execution  of  this  Agreement  and  the  consummation  of  the  transactions
contemplated  hereby  or  thereby, other than filings required under federal and
state  securities  laws.

          2.7     Compliance  with  Other  Instruments.
                  ------------------------------------

                (a)     Each  of the Company and the Subsidiary is in compliance
with  each,  and is not in violation or default of any, provision of its charter
documents  or  bylaws,  or  judgment,  order,  writ,  or decree, or any material
contract,  agreement,  instrument,  or  commitment  to which it is a party or by
which  it  is  bound,  or  material  provision  of  any  statute,  law, rule, or
regulation  applicable  to  the  Company  or  the Subsidiary, its assets, or its
business.  There  is  no term or provision in any of the foregoing documents and
instruments which materially adversely affects the business (as now conducted or
as  proposed  to  be conducted), assets or financial condition of the Company or
the  Subsidiary.  The  execution, delivery, and performance of this Agreement or
any  of  the  Ancillary  Agreements  and  the  consummation  of the transactions
contemplated  hereby  and thereby will not result in any such violation or be in
conflict  with  or  constitute, with or without the passage of time or giving of
notice,  either a default under any such provision, instrument, judgment, order,
writ,  decree, or contract or an event that results in the creation or any lien,
charge,  or encumbrance upon any assets of the Company or the Subsidiary.  There
are  no  outstanding  puts,  calls,  commitments,  anti-dilution  or  ratchet
protections,  proxy or voting trust agreements, preemptive, change of control or
similar  rights  or other agreements to which the Company or the Subsidiary is a
party  or by which the Company or the Subsidiary is otherwise bound which relate
to, restrict or affect any of the capital stock of the Company or the Subsidiary
that  any  person  or entity would be entitled to exercise or invoke as a result
of,  or  in connection with, the purchase by the Investor of the Common Stock or
which  are  otherwise  in  effect.

          2.8     Registration  Rights.  Except  for  the  registration  rights
                  --------------------
provided  to the Investor, neither the Company nor the Subsidiary has granted or
agreed to grant any registration rights, including without limitation any demand
or  piggyback  rights,  to  any  person  or  entity.

     2.9     Legal  Proceedings.  Except as set forth on Schedule 2.9, there are
             ------------------                          ------------
no  actions or proceedings pending or, to the actual knowledge of the Company or
the  Subsidiary, threatened against, relating to or affecting the Company or the
Subsidiary.

     2.10     Intellectual Property.  There is not pending nor, to the Company's
              ---------------------
knowledge,  threatened any action, suit, investigation, or proceeding contesting
or challenging the rights of the Company or the Subsidiary in or to any material
item of intellectual property owned or used by the Company or the Subsidiary, in
the  conduct  of  its business (the "Intellectual Property"), or the validity of
any  of  the  Intellectual  Property.

     2.11     SEC  Documents;  Financial  Statements.  Except  as  set  forth on
              --------------------------------------
Schedule  2.11,  the  Company  is  subject to periodic reporting requirements of
     ---------
Section  15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"),  and,  the  Company  has  timely  filed  all  reports,  schedules, forms,
statements  and other documents required to be filed by it with the SEC pursuant
to  the  reporting  requirements  of  the Exchange Act, including material filed
pursuant  to  Section  13(a)  or 15(d) of the Exchange Act (all of the foregoing
including  filings incorporated by reference therein being referred to herein as
the  "SEC  Documents").  As  of their respective filing dates, the SEC Documents
complied  in all material respects with the requirements of the Exchange Act and
the  rules  and regulations of the SEC promulgated thereunder applicable to such
documents,  and,  as of their respective filing dates, none of the SEC Documents
contained any untrue statement of a material fact or omitted to state a material
fact  required to be stated therein or necessary in order to make the statements
therein,  in  light  of  the  circumstances  under  which  they  were  made, not
misleading.  The  financial  statements  of  the  Company  included  in  the SEC
Documents  comply as to form in all material respects with applicable accounting
requirements  and  the  published  rules  and  regulations  of  the SEC or other
applicable  rules  and  regulations  with  respect  thereto.  Such  financial
statements  have  been prepared in accordance with generally accepted accounting
principles  ("GAAP")  applied  on a consistent basis during the periods involved
(except  (i)  as  may be otherwise indicated in such financial statements or the
notes  thereto,  or  (ii)  in  the  case of unaudited interim statements, to the
extent  they  may  not  include  footnotes  or  may  be  condensed  or  summary
statements),  and fairly present in all material respects the financial position
of  the Company and its subsidiaries, as of the dates thereof and the results of
operations  and  cash  flows for the periods then ended (subject, in the case of
unaudited  statements,  to  normal  year-end  audit  adjustments).

     2.12     No  Material  Adverse  Event.  Except  as listed on Schedule 2.12,
              ----------------------------                        -------------
since  September 30, 2002, no material adverse event has occurred or exists with
respect  to  the  Company  or  its  subsidiaries).

     3.     Representations and Warranties of the Investor.  The Investor hereby
            ----------------------------------------------
represents  and  warrants  that:

     3.1     Authorization.  This  Agreement  constitutes  a  valid  and legally
             -------------
binding  obligation,  enforceable against Investor in accordance with its terms.

          3.2     Purchase  Entirely  for  Own  Account.  This Agreement is made
                  -------------------------------------
with the Investor in reliance upon the Investor's representation to the Company,
which  by  the  Investor's  execution  of  this  Agreement  the  Investor hereby
confirms,  that the Common Stock to be received by the Investor will be acquired
for  investment  for  the Investor's own account, not as a nominee or agent, and
not  with a view to the resale or distribution of any part thereof, and that the
Investor  has no present intention of selling, granting any participation in, or
otherwise  distributing  the  same,  by  executing this Agreement, each Investor
further  represents  that  the Investor does not have any contract, undertaking,
agreement,  or  arrangement  with  any  person  to  sell,  transfer,  or  grant
participation  to such person or to any third person, with respect to any of the
Securities.  The  Investor  represents  that  it has full power and authority to
enter  into  this  Agreement.

          3.3     Restricted  Securities.  The  Investor  understands  that  the
                  ----------------------
shares of Common Stock it is purchasing constitute "restricted securities" under
the federal securities laws inasmuch as they are being acquired from the Company
in  a  transaction  not involving a public offering and that under such laws and
applicable  regulations  such  securities may not be resold without registration
under  the  Securities  Act  of  1933, as amended (the "Act"), except in certain
limited  circumstances.  In  this connection, the Investor represents that it is
familiar  with  Rule  144 under the Act, as presently in effect, and understands
the  resale  limitations  imposed  thereby  and  by  the  Act.

          3.4     Further  Limitations  on  Disposition.  Without  in  any  way
                  -------------------------------------
limiting the representations set forth above, the Investor further agrees not to
make  any  disposition of all or any portion of the Securities unless and until:

               (a)     there  is  then  in effect a registration statement under
the  Act  covering  such  proposed  disposition  and such disposition is made in
accordance  with  such  registration  statement;  or

               (b)  (i)  the  Investor  shall  have  notified the Company of the
proposed  disposition  and  shall  have  furnished  the  Company with a detailed
statement of the circumstances surrounding the proposed disposition, and (ii) if
reasonably  requested  by  the  Company,  the  Investor shall have furnished the
Company with an opinion of counsel, reasonably satisfactory to the Company, that
such  disposition  will  not  require registration of such shares under the Act.

          3.8     Legends. It is understood that the certificates evidencing the
                  -------
Common  Stock  (and  the Common Stock issuable upon conversion thereof) may bear
the  following  legend:

These securities have not been registered under the Securities Act of 1933. They
may  not be sold, offered for sale, pledged, or hypothecated in the absence of a
registration  statement  in effect with respect to the securities under such Act
or  an  opinion  of  counsel  reasonably  satisfactory  to the Company that such
registration  is  not  required.

     3.9     Accredited  Investor.  The  Investor is an "accredited investor" as
             --------------------
such  term  is  defined  in  Rule  501  under  the  Act.

     4.  Conditions of Investor's Obligations at Closing.  The obligation of the
         -----------------------------------------------
Investor under Section 1.1(b) of this Agreement is subject to the fulfillment on
or  before  the Closing of each of the following conditions, the waiver of which
shall not be effective against the Investor unless consented thereto in writing:

          4.1     Representations  and  Warranties.  The  representations  and
                  --------------------------------
warranties  of  the  Company  and the Subsidiary contained in Section 2 shall be
true  on  and  as  of  the  Closing  with  the  same  effect  as  though  such
representations  and  warranties  had  been  made  on and as of the date of such
Closing.

          4.2     Performance.  The  Company  shall  have performed and complied
                  -----------
with  all  agreements,  obligations,  and conditions contained in this Agreement
that  are  required  to  be  performed  or  complied with by it on or before the
Closing.

     4.3     Proceedings  and Documents.  All corporate and other proceedings in
             --------------------------
connection  with  the transactions contemplated at the Closing and all documents
incident  thereto  shall be reasonably satisfactory in form and substance to the
Investor  and  Investor's counsel, if any, and they shall have received all such
counterpart original and certified or other copies of such documents as they may
reasonably  request.

     4.4     Blue-Sky  Compliance.  The  Company  shall  have  complied with all
             --------------------
requirements  of federal and state securities or "Blue Sky" laws with respect to
the  issuance  of  the  Common  Stock  to  the  Investor  hereunder.

     4.5     Stock  Certificates.  The  Company shall deliver to the Investor at
             -------------------
the  Closing  a  stock  certificate or certificates evidencing the Common Stock.

     4.6     Registration Rights Agreement.  The Company shall have executed and
             -----------------------------
delivered to the Investor the Registration Rights Agreement substantially in the
form  attached  hereto  as  Exhibit  A.

     4.7     Shareholders  Agreement.   The Company, the Investor, certain other
             ------------------------
investors and Michael Dent shall have executed and delivered to the Investor the
Shareholders  Agreement  substantially in the form attached hereto as Exhibit B.

     5.     Conditions of the Company's Obligations at Closing.  The obligations
            --------------------------------------------------
of  the  Company  to  the  Investor  under  this  Agreement  are  subject to the
fulfillment  on or before the Closing of each of the following conditions by the
Investor:

          5.1     Representations  and  Warranties.  The  representations  and
                  --------------------------------
warranties  of  the  Investor contained in Section 3 shall be true on and as the
Closing  with the same effect as though such representations and warranties have
been  made  on  and  as  of  the  Closing.

          5.2     Payment  of  Purchase  Price.     The  Investor  shall  have
                  ----------------------------
delivered  the  purchase  price  specified  in  Section  1.1.

     7.     Covenants  of  the  Company  and  the  Subsidiary.
            -------------------------------------------------

          7.1     Inspection.  Each of the Company shall permit the Investor, at
                  ----------
the  Investor's expense, to visit and inspect the Company's and the Subsidiary's
properties,  to  examine  its books of account and records, and to discuss their
respective  affairs,  finances, and accounts with their respective officers, all
at  such  reasonable  times  as  may  be  requested  by the Investor;  provided,
however, that neither the Company not the Subsidiary shall be obligated pursuant
to  this  Section  7.1  to provide access to any information which it reasonably
considers  to  be a trade secret, the disclosure of which the Company reasonably
believes  may  adversely  affect  its  business.

     8.     Miscellaneous.
            -------------

          8.1     Survival  of Warranties.  The warranties, representations, and
                  -----------------------
covenants  of  the  Company  and  Investor contained in or made pursuant to this
Agreement  shall  survive  the execution  and delivery of this Agreement and the
Closing  and  shall  in  no  way be affected by any investigation of the subject
matter  thereof  made  by  or  on  behalf  of  the  Investor  or  the  Company.

          8.2     Successors  and  Assigns.  The  terms  and  conditions of this
                  ------------------------
Agreement  shall  inure  to  the  benefit  of and be binding upon the respective
heirs,  legal representatives, successors and assigns of the parties. Nothing in
this  Agreement,  express or implied, is intended to confer upon any party other
than  the  parties  hereto  or  their  respective  heirs, legal representatives,
successors  and  assigns any rights, remedies, obligations, or liabilities under
or  by reason of this Agreement, except as expressly provided in this Agreement.
Neither  this Agreement nor any of the rights and obligations created hereby can
be  assigned by the Company, and any such attempted assignment will be void. Any
Investor can transfer all or any portion of its rights and obligations hereunder
to  any  other person or entity selected by the Investor who is not a competitor
of  the  Company.

     8.3     Governing Law; Jurisdiction; Jury Trial.  The corporate laws of the
             ---------------------------------------
State  of  Nevada  shall govern all issues concerning the relative rights of the
Company  and  its shareholders. All other questions concerning the construction,
validity,  enforcement and interpretation of this Agreement shall be governed by
the  internal  laws of the State of Florida, without giving effect to any choice
of  law or conflict of law provision or rule (whether of the State of Florida or
any  other  jurisdictions)  that  would cause the application of the laws of any
jurisdictions  other  than  the State of Florida.  Each party hereby irrevocably
submits to the jurisdiction of the Circuit Court for Collier County, Florida and
the  United  States  District  Court  for the Middle District of Florida for the
adjudication  of  any  dispute  hereunder  or in connection herewith or with any
transaction  contemplated  hereby  or  discussed  herein, and hereby irrevocably
waives,  and  agrees  not to assert in any suit, action or proceeding, any claim
that  it  is  not personally subject to the jurisdiction of any such court, that
such  suit, action or proceeding is brought in an inconvenient forum or that the
venue  of  such  suit,  action  or  proceeding  is  improper.  EACH PARTY HEREBY
IRREVOCABLY  WAIVES  ANY  RIGHT  IT  MAY HAVE, AND AGREES NOT TO REQUEST, A JURY
TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR
ARISING  OUT  OF  THIS  AGREEMENT  OR  ANY  TRANSACTION  CONTEMPLATED  HEREBY.

          8.4     Counterparts.  This  Agreement  may be executed in two or more
                  ------------
counterparts,  each  of  which  shall  be  deemed  an original, but all of which
together  shall  constitute  one  and  the  same  instrument.

          8.5     Titles  and  Subtitles.  The titles and subtitles used in this
                  ----------------------
Agreement  are  used  for  convenience  only  and  are  not  to be considered in
construing  or  interpreting  this  Agreement.

          8.6     Notices.  Unless  otherwise  provided,  any notice required or
                  -------
permitted  under  this  Agreement  shall be given in writing and shall be deemed
effectively  given  upon  personal  delivery to the party to be notified or upon
deposit  with  the  United  States Post Office, by registered or certified mail,
postage  prepaid  and  addressed  to  the  party  to  be notified at the address
indicated  for such party on the signature page hereof, or at such other address
as  such  party  may  designate  by ten (10) days' advance written notice to the
other  parties.

          8.7     Finder's  Fee.  Each  party  represents that it neither is nor
                  -------------
will  be  obligated  for  any finders' fee or commission in connection with this
transaction,  except  for  a payment of 40,000 shares of Common Stock and $4,000
payable by the Company to Technology Capital Group, Inc.  The Investor agrees to
indemnify  and  to  hold  harmless  the  Company  from  any  liability  for  any
commission  or  compensation  in the nature of a finders' fee (and the costs and
expenses  of  defending against such liability or  asserted liability) for which
the  Investor or any of its officers, partners, employees, or representatives is
responsible. The Company agrees to indemnify and hold harmless the Investor from
any liability for any commission or compensation in the nature of a finders' fee
(and  the  costs  and  expenses  of defending against such liability or asserted
liability)  for  which  the  Company  or  any  of  its  officers,  employees, or
representatives  is  responsible.

     8.8     Expenses.  Except  as  otherwise  expressly  provided  in  this
             --------
Agreement,  whether or not the transactions contemplated hereby are consummated,
each  party  will pay its own costs and expenses incurred in connection with the
negotiation,  execution,  performance  and  closing  of  this  Agreement and the
transactions  contemplated  hereby.

          8.9     Amendments  and  Waivers.  Any  term  of this Agreement may be
                  ------------------------
amended  and  the observance of any term of this Agreement may be waived (either
generally  or  in  a  particular  instance  and  either  retroactively  or
prospectively),  only  with the written consent of the Company and the Investor.

          8.10     Severability. If one or more provisions of this Agreement are
                   ------------
held to be unenforceable under applicable law, such provisions shall be excluded
from  this Agreement and the balance of the Agreement shall be interpreted as if
such provisions were so excluded and shall be enforceable in accordance with its
terms.

                    [Signatures Appear on the Following Page]
<PAGE>

          IN  WITNESS  WHEREOF,  the  undersigned have executed, or caused to be
executed  on  their behalf by an agent thereunto duly authorized, this Agreement
as  of  the  date  first  above  written.

                                   NEOGENOMICS,  INC.
                                   A  Nevada  Corporation

                                   By:___________________________
                                   Name:   Michael  Dent
                                   Title:     Chief  Executive  Officer

                                   NEOGENOMICS,  INC.
                                   A  Florida  Corporation

                                   By:___________________________
                                   Name:   Michael  Dent
                                   Title:     Chief  Executive  Officer

                                   The  Investor:

                                   ________________________________
                                   Steven  C.  Jones
                                   Address:
                                   1740  Persimmon  Drive
                                   Naples,  FL  34109STOCK PURCHASE AGREEMENT

     This  STOCK  PURCHASE  AGREEMENT (this "Agreement") is made as of April 15,
2003  by  and  between NeoGenomics, Inc., a Nevada corporation, (the "Company"),
NeoGenomics,  Inc.,  a  Florida corporation and a wholly-owned subsidiary of the
Company  (the  "Subsidiary"), and Larry Kuhnert, an individual (the "Investor").

     THE  PARTIES  HEREBY  AGREE  AS  FOLLOWS:

1.     Purchase  and  Sale  of  Stock.

          1.1     Sale  and  Issuance  of Common Stock.     Subject to the terms
                  ------------------------------------
and  conditions  of this Agreement, and in reliance upon the representations and
warranties  and  covenants  contained herein, the Investor agrees to purchase at
the  Closing,  and  the  Company agrees to sell and issue to the Investor at the
Closing  (as  defined  herein),  1,541,261 shares of the Company's Common Stock,
$.001  par  value  (the  "Common  Stock")  for  the  aggregate purchase price of
$15,412.61.

          1.2     Closing.  The purchase and sale of the Common Stock shall take
                  -------
place  at  the  offices of Membrado & Montell, LLP, New York, New York, at 10:00
A.M.,  on  April 15, 2003 or at such other time and place as the Company and the
Investor agree upon orally or in writing (which time and place are designated as
the  "Closing").  At  the  Closing,  the  Company  shall deliver to the Investor
certificates  (in  the denominations requested by the Investor) representing the
Common Stock which the Investor is purchasing against delivery to the Company by
the  Investor  of  the  full  purchase  price  therefor,  which shall be paid by
cashier's  or  bank  check payable to the Company's order or by wire transfer to
such  account  as  the  Company  shall  designate.

          1.3     Requirement  of  Purchase  Price Delivery.  No purchase of any
                  -----------------------------------------
shares of Common Stock hereof shall be deemed to have been made pursuant to this
Agreement  and no rights hereunder shall inure to the Investor, unless the total
purchase  price  for  the  Common  Stock is delivered at the Closing pursuant to
Section  1.2  hereof.

     2.     Representations  and Warranties of the Company.  The Company and the
            ----------------------------------------------
Subsidiary  hereby  represents  and  warrants  to  the  Investor  that:

          2.1     Organization  and  Good Standing.  Each of the Company and the
                  --------------------------------
Subsidiary  is  a  corporation  duly  organized,  validly  existing, and in good
standing  under  the  laws  of  its  state of organization and has all requisite
corporate  power  and authority to carry on its business as now conducted and as
proposed  to  be conducted.  Each of the Company and the Subsidiary is qualified
to  do  business  in  each  jurisdictions  where such qualification is required,
except  where  the  lack of such qualification would not have a material adverse
effect  on  the business or assets of the Company and the Subsidiary, taken as a
whole.

          2.2     Capitalization.    The  current  capitalization of the Company
                  --------------
is  as  follows:

               (a)     Common  Stock:  There  are  currently one hundred million
                       -------------
(100,000,000)  authorized  shares of Common Stock, par value $.001 per share, of
which  18,409,416  shares  are issued and outstanding after giving effect to the
transactions  contemplated  hereby.

               (b)     On  a  Fully-Diluted Basis:  Except for (i) 40,000 shares
                       --------------------------
which  the  Company  intends  to  issue  to Technology Capital Group, Inc., (ii)
20,000  shares  which  the  Company  intends to issue to its Scientific Advisory
Board,  and (iii) an option to acquire 100,000 shares at the market price on the
date of issuance, which the Company intends to issue to a member of its Board of
Directors,  there  are  not outstanding any options, warrants, rights (including
conversion  or preemptive rights), or agreements for the purchase or acquisition
from  the  Company  or, to the knowledge of the Company from any shareholder, of
any  shares  of  the  capital  stock  of  the  Company.

          2.3     Subsidiaries.  Except for the Subsidiary, the Company does not
                  ------------
presently  own  or  control,  directly  or indirectly, any interest in any other
corporation,  association,  or  other  business  entity.

          2.4     Authorization.  All  corporate  action  on  the  part  of  the
                  -------------
Company  and  the  Subsidiary,  and  their  respective  officers, directors, and
shareholders  necessary  for  the authorization, execution, and delivery of this
Agreement  and the agreements attached as exhibits hereto (such agreements being
herein  referred  to  as  the  "Ancillary  Agreements"),  the performance of all
obligations of the Company and/or the Subsidiary under each of the Agreement and
the  Ancillary  Agreements,  and the authorization, issuance (or reservation for
issuance),  and delivery of the Common Stock being sold hereunder has been taken
or  will  be  taken  prior  to the Closing, and this Agreement and the Ancillary
Agreements  constitute (or will constitute upon the execution thereof) the valid
and  legally  binding  obligations  of the Company and/or the Subsidiary, as the
case  may  be,  and each of the other parties thereto (other than the Investor),
enforceable  in  accordance  with  their  respective terms.  The Company and the
Subsidiary  has  the  requisite  corporate  power  to enter into and perform its
obligations  under  this  Agreement  and  the  Ancillary  Agreements.

           2.5     Valid  Issuance  of  Common  Stock.
                   ----------------------------------

                (a)     The  Common  Stock  which  is  being  purchased  by  the
Investor  hereunder,  when  issued,  sold,  and delivered in accordance with the
terms  hereof  or  thereof,  will  be  duly  and  validly issued, fully paid and
nonassessable  free  and clear of any taxes, liens, claims, preemptive rights or
similar  rights  or  encumbrances imposed by or through the Company or under law
and,  assuming  the  accuracy  of  the  representations  of the Investor in this
Agreement,  will  be issued in compliance with all applicable federal  and state
securities  laws.

               (b)     The  outstanding  shares of Common Stock are all duly and
validly  authorized and issued, fully paid and nonassessable, were not issued in
violation of the terms of any contract binding upon the Company, and were issued
in  compliance  with  all  applicable  federal  and  state  securities  laws.

          2.6     Governmental  Consents.  No  consent,  approval,  order,  or
                  ----------------------
authorization  of,  or registration, qualification, designation, declaration, or
filing  with, any federal, state, local, or provincial governmental authority on
the  part  of  the  Company or the Subsidiary is required in connection with the
execution  of  this  Agreement  and  the  consummation  of  the  transactions
contemplated  hereby  or  thereby, other than filings required under federal and
state  securities  laws.

          2.7     Compliance  with  Other  Instruments.
                  ------------------------------------

                (a)     Each  of the Company and the Subsidiary is in compliance
with  each,  and is not in violation or default of any, provision of its charter
documents  or  bylaws,  or  judgment,  order,  writ,  or decree, or any material
contract,  agreement,  instrument,  or  commitment  to which it is a party or by
which  it  is  bound,  or  material  provision  of  any  statute,  law, rule, or
regulation  applicable  to  the  Company  or  the Subsidiary, its assets, or its
business.  There  is  no term or provision in any of the foregoing documents and
instruments which materially adversely affects the business (as now conducted or
as  proposed  to  be conducted), assets or financial condition of the Company or
the  Subsidiary.  The  execution, delivery, and performance of this Agreement or
any  of  the  Ancillary  Agreements  and  the  consummation  of the transactions
contemplated  hereby  and thereby will not result in any such violation or be in
conflict  with  or  constitute, with or without the passage of time or giving of
notice,  either a default under any such provision, instrument, judgment, order,
writ,  decree, or contract or an event that results in the creation or any lien,
charge,  or encumbrance upon any assets of the Company or the Subsidiary.  There
are  no  outstanding  puts,  calls,  commitments,  anti-dilution  or  ratchet
protections,  proxy or voting trust agreements, preemptive, change of control or
similar  rights  or other agreements to which the Company or the Subsidiary is a
party  or by which the Company or the Subsidiary is otherwise bound which relate
to, restrict or affect any of the capital stock of the Company or the Subsidiary
that  any  person  or entity would be entitled to exercise or invoke as a result
of,  or  in connection with, the purchase by the Investor of the Common Stock or
which  are  otherwise  in  effect.

          2.8     Registration  Rights.  Except  for  the  registration  rights
                  --------------------
provided  to the Investor, neither the Company nor the Subsidiary has granted or
agreed to grant any registration rights, including without limitation any demand
or  piggyback  rights,  to  any  person  or  entity.

     2.9     Legal  Proceedings.  Except as set forth on Schedule 2.9, there are
             ------------------                          ------------
no  actions or proceedings pending or, to the actual knowledge of the Company or
the  Subsidiary, threatened against, relating to or affecting the Company or the
Subsidiary.

     2.10     Intellectual Property.  There is not pending nor, to the Company's
              ---------------------
knowledge,  threatened any action, suit, investigation, or proceeding contesting
or challenging the rights of the Company or the Subsidiary in or to any material
item of intellectual property owned or used by the Company or the Subsidiary, in
the  conduct  of  its business (the "Intellectual Property"), or the validity of
any  of  the  Intellectual  Property.

     2.11     SEC  Documents;  Financial  Statements.  Except  as  set  forth on
              --------------------------------------
Schedule  2.11,  the  Company  is  subject to periodic reporting requirements of
     ---------
Section  15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"),  and,  the  Company  has  timely  filed  all  reports,  schedules, forms,
statements  and other documents required to be filed by it with the SEC pursuant
to  the  reporting  requirements  of  the Exchange Act, including material filed
pursuant  to  Section  13(a)  or 15(d) of the Exchange Act (all of the foregoing
including  filings incorporated by reference therein being referred to herein as
the  "SEC  Documents").  As  of their respective filing dates, the SEC Documents
complied  in all material respects with the requirements of the Exchange Act and
the  rules  and regulations of the SEC promulgated thereunder applicable to such
documents,  and,  as of their respective filing dates, none of the SEC Documents
contained any untrue statement of a material fact or omitted to state a material
fact  required to be stated therein or necessary in order to make the statements
therein,  in  light  of  the  circumstances  under  which  they  were  made, not
misleading.  The  financial  statements  of  the  Company  included  in  the SEC
Documents  comply as to form in all material respects with applicable accounting
requirements  and  the  published  rules  and  regulations  of  the SEC or other
applicable  rules  and  regulations  with  respect  thereto.  Such  financial
statements  have  been prepared in accordance with generally accepted accounting
principles  ("GAAP")  applied  on a consistent basis during the periods involved
(except  (i)  as  may be otherwise indicated in such financial statements or the
notes  thereto,  or  (ii)  in  the  case of unaudited interim statements, to the
extent  they  may  not  include  footnotes  or  may  be  condensed  or  summary
statements),  and fairly present in all material respects the financial position
of  the Company and its subsidiaries, as of the dates thereof and the results of
operations  and  cash  flows for the periods then ended (subject, in the case of
unaudited  statements,  to  normal  year-end  audit  adjustments).

     2.12     No  Material  Adverse  Event.  Except  as listed on Schedule 2.12,
              ----------------------------                        -------------
since  September 30, 2002, no material adverse event has occurred or exists with
respect  to  the  Company  or  its  subsidiaries).

     3.     Representations and Warranties of the Investor.  The Investor hereby
            ----------------------------------------------
represents  and  warrants  that:

     3.1     Authorization.  This  Agreement  constitutes  a  valid  and legally
             -------------
binding  obligation,  enforceable against Investor in accordance with its terms.

          3.2     Purchase  Entirely  for  Own  Account.  This Agreement is made
                  -------------------------------------
with the Investor in reliance upon the Investor's representation to the Company,
which  by  the  Investor's  execution  of  this  Agreement  the  Investor hereby
confirms,  that the Common Stock to be received by the Investor will be acquired
for  investment  for  the Investor's own account, not as a nominee or agent, and
not  with a view to the resale or distribution of any part thereof, and that the
Investor  has no present intention of selling, granting any participation in, or
otherwise  distributing  the  same,  by  executing this Agreement, each Investor
further  represents  that  the Investor does not have any contract, undertaking,
agreement,  or  arrangement  with  any  person  to  sell,  transfer,  or  grant
participation  to such person or to any third person, with respect to any of the
Securities.  The  Investor  represents  that  it has full power and authority to
enter  into  this  Agreement.

          3.3     Restricted  Securities.  The  Investor  understands  that  the
                  ----------------------
shares of Common Stock it is purchasing constitute "restricted securities" under
the federal securities laws inasmuch as they are being acquired from the Company
in  a  transaction  not involving a public offering and that under such laws and
applicable  regulations  such  securities may not be resold without registration
under  the  Securities  Act  of  1933, as amended (the "Act"), except in certain
limited  circumstances.  In  this connection, the Investor represents that it is
familiar  with  Rule  144 under the Act, as presently in effect, and understands
the  resale  limitations  imposed  thereby  and  by  the  Act.

          3.4     Further  Limitations  on  Disposition.  Without  in  any  way
                  -------------------------------------
limiting the representations set forth above, the Investor further agrees not to
make  any  disposition of all or any portion of the Securities unless and until:

               (a)     there  is  then  in effect a registration statement under
the  Act  covering  such  proposed  disposition  and such disposition is made in
accordance  with  such  registration  statement;  or

               (b)  (i)  the  Investor  shall  have  notified the Company of the
proposed  disposition  and  shall  have  furnished  the  Company with a detailed
statement of the circumstances surrounding the proposed disposition, and (ii) if
reasonably  requested  by  the  Company,  the  Investor shall have furnished the
Company with an opinion of counsel, reasonably satisfactory to the Company, that
such  disposition  will  not  require registration of such shares under the Act.

          3.8     Legends. It is understood that the certificates evidencing the
                  -------
Common  Stock  (and  the Common Stock issuable upon conversion thereof) may bear
the  following  legend:

These securities have not been registered under the Securities Act of 1933. They
may  not be sold, offered for sale, pledged, or hypothecated in the absence of a
registration  statement  in effect with respect to the securities under such Act
or  an  opinion  of  counsel  reasonably  satisfactory  to the Company that such
registration  is  not  required.

     3.9     Accredited  Investor.  The  Investor is an "accredited investor" as
             --------------------
such  term  is  defined  in  Rule  501  under  the  Act.

     4.  Conditions of Investor's Obligations at Closing.  The obligation of the
         -----------------------------------------------
Investor under Section 1.1(b) of this Agreement is subject to the fulfillment on
or  before  the Closing of each of the following conditions, the waiver of which
shall not be effective against the Investor unless consented thereto in writing:

          4.1     Representations  and  Warranties.  The  representations  and
                  --------------------------------
warranties  of  the  Company  and the Subsidiary contained in Section 2 shall be
true  on  and  as  of  the  Closing  with  the  same  effect  as  though  such
representations  and  warranties  had  been  made  on and as of the date of such
Closing.

          4.2     Performance.  The  Company  shall  have performed and complied
                  -----------
with  all  agreements,  obligations,  and conditions contained in this Agreement
that  are  required  to  be  performed  or  complied with by it on or before the
Closing.

     4.3     Proceedings  and Documents.  All corporate and other proceedings in
             --------------------------
connection  with  the transactions contemplated at the Closing and all documents
incident  thereto  shall be reasonably satisfactory in form and substance to the
Investor  and  Investor's counsel, if any, and they shall have received all such
counterpart original and certified or other copies of such documents as they may
reasonably  request.

     4.4     Blue-Sky  Compliance.  The  Company  shall  have  complied with all
             --------------------
requirements  of federal and state securities or "Blue Sky" laws with respect to
the  issuance  of  the  Common  Stock  to  the  Investor  hereunder.

     4.5     Stock  Certificates.  The  Company shall deliver to the Investor at
             -------------------
the  Closing  a  stock  certificate or certificates evidencing the Common Stock.

     4.6     Registration Rights Agreement.  The Company shall have executed and
             -----------------------------
delivered to the Investor the Registration Rights Agreement substantially in the
form  attached  hereto  as  Exhibit  A.

     4.7     Shareholders  Agreement.   The Company, the Investor, certain other
             ------------------------
investors and Michael Dent shall have executed and delivered to the Investor the
Shareholders  Agreement  substantially in the form attached hereto as Exhibit B.

     5.     Conditions of the Company's Obligations at Closing.  The obligations
            --------------------------------------------------
of  the  Company  to  the  Investor  under  this  Agreement  are  subject to the
fulfillment  on or before the Closing of each of the following conditions by the
Investor:

          5.1     Representations  and  Warranties.  The  representations  and
                  --------------------------------
warranties  of  the  Investor contained in Section 3 shall be true on and as the
Closing  with the same effect as though such representations and warranties have
been  made  on  and  as  of  the  Closing.

          5.2     Payment  of  Purchase  Price.     The  Investor  shall  have
                  ----------------------------
delivered  the  purchase  price  specified  in  Section  1.1.

     7.     Covenants  of  the  Company  and  the  Subsidiary.
            -------------------------------------------------

          7.1     Inspection.  Each of the Company shall permit the Investor, at
                  ----------
the  Investor's expense, to visit and inspect the Company's and the Subsidiary's
properties,  to  examine  its books of account and records, and to discuss their
respective  affairs,  finances, and accounts with their respective officers, all
at  such  reasonable  times  as  may  be  requested  by the Investor;  provided,
however, that neither the Company not the Subsidiary shall be obligated pursuant
to  this  Section  7.1  to provide access to any information which it reasonably
considers  to  be a trade secret, the disclosure of which the Company reasonably
believes  may  adversely  affect  its  business.

     8.     Miscellaneous.
            -------------

          8.1     Survival  of Warranties.  The warranties, representations, and
                  -----------------------
covenants  of  the  Company  and  Investor contained in or made pursuant to this
Agreement  shall  survive  the execution  and delivery of this Agreement and the
Closing  and  shall  in  no  way be affected by any investigation of the subject
matter  thereof  made  by  or  on  behalf  of  the  Investor  or  the  Company.

          8.2     Successors  and  Assigns.  The  terms  and  conditions of this
                  ------------------------
Agreement  shall  inure  to  the  benefit  of and be binding upon the respective
heirs,  legal representatives, successors and assigns of the parties. Nothing in
this  Agreement,  express or implied, is intended to confer upon any party other
than  the  parties  hereto  or  their  respective  heirs, legal representatives,
successors  and  assigns any rights, remedies, obligations, or liabilities under
or  by reason of this Agreement, except as expressly provided in this Agreement.
Neither  this Agreement nor any of the rights and obligations created hereby can
be  assigned by the Company, and any such attempted assignment will be void. Any
Investor can transfer all or any portion of its rights and obligations hereunder
to  any  other person or entity selected by the Investor who is not a competitor
of  the  Company.

     8.3     Governing Law; Jurisdiction; Jury Trial.  The corporate laws of the
             ---------------------------------------
State  of  Nevada  shall govern all issues concerning the relative rights of the
Company  and  its shareholders. All other questions concerning the construction,
validity,  enforcement and interpretation of this Agreement shall be governed by
the  internal  laws of the State of Florida, without giving effect to any choice
of  law or conflict of law provision or rule (whether of the State of Florida or
any  other  jurisdictions)  that  would cause the application of the laws of any
jurisdictions  other  than  the State of Florida.  Each party hereby irrevocably
submits to the jurisdiction of the Circuit Court for Collier County, Florida and
the  United  States  District  Court  for the Middle District of Florida for the
adjudication  of  any  dispute  hereunder  or in connection herewith or with any
transaction  contemplated  hereby  or  discussed  herein, and hereby irrevocably
waives,  and  agrees  not to assert in any suit, action or proceeding, any claim
that  it  is  not personally subject to the jurisdiction of any such court, that
such  suit, action or proceeding is brought in an inconvenient forum or that the
venue  of  such  suit,  action  or  proceeding  is  improper.  EACH PARTY HEREBY
IRREVOCABLY  WAIVES  ANY  RIGHT  IT  MAY HAVE, AND AGREES NOT TO REQUEST, A JURY
TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR
ARISING  OUT  OF  THIS  AGREEMENT  OR  ANY  TRANSACTION  CONTEMPLATED  HEREBY.

          8.4     Counterparts.  This  Agreement  may be executed in two or more
                  ------------
counterparts,  each  of  which  shall  be  deemed  an original, but all of which
together  shall  constitute  one  and  the  same  instrument.

          8.5     Titles  and  Subtitles.  The titles and subtitles used in this
                  ----------------------
Agreement  are  used  for  convenience  only  and  are  not  to be considered in
construing  or  interpreting  this  Agreement.

          8.6     Notices.  Unless  otherwise  provided,  any notice required or
                  -------
permitted  under  this  Agreement  shall be given in writing and shall be deemed
effectively  given  upon  personal  delivery to the party to be notified or upon
deposit  with  the  United  States Post Office, by registered or certified mail,
postage  prepaid  and  addressed  to  the  party  to  be notified at the address
indicated  for such party on the signature page hereof, or at such other address
as  such  party  may  designate  by ten (10) days' advance written notice to the
other  parties.

          8.7     Finder's  Fee.  Each  party  represents that it neither is nor
                  -------------
will  be  obligated  for  any finders' fee or commission in connection with this
transaction,  except  for  a payment of 40,000 shares of Common Stock and $4,000
payable by the Company to Technology Capital Group, Inc.  The Investor agrees to
indemnify  and  to  hold  harmless  the  Company  from  any  liability  for  any
commission  or  compensation  in the nature of a finders' fee (and the costs and
expenses  of  defending against such liability or  asserted liability) for which
the  Investor or any of its officers, partners, employees, or representatives is
responsible. The Company agrees to indemnify and hold harmless the Investor from
any liability for any commission or compensation in the nature of a finders' fee
(and  the  costs  and  expenses  of defending against such liability or asserted
liability)  for  which  the  Company  or  any  of  its  officers,  employees, or
representatives  is  responsible.

     8.8     Expenses.  Except  as  otherwise  expressly  provided  in  this
             --------
Agreement,  whether or not the transactions contemplated hereby are consummated,
each  party  will pay its own costs and expenses incurred in connection with the
negotiation,  execution,  performance  and  closing  of  this  Agreement and the
transactions  contemplated  hereby.

          8.9     Amendments  and  Waivers.  Any  term  of this Agreement may be
                  ------------------------
amended  and  the observance of any term of this Agreement may be waived (either
generally  or  in  a  particular  instance  and  either  retroactively  or
prospectively),  only  with the written consent of the Company and the Investor.

          8.10     Severability. If one or more provisions of this Agreement are
                   ------------
held to be unenforceable under applicable law, such provisions shall be excluded
from  this Agreement and the balance of the Agreement shall be interpreted as if
such provisions were so excluded and shall be enforceable in accordance with its
terms.

                    [Signatures Appear on the Following Page]
<PAGE>

          IN  WITNESS  WHEREOF,  the  undersigned have executed, or caused to be
executed  on  their behalf by an agent thereunto duly authorized, this Agreement
as  of  the  date  first  above  written.

                                   NEOGENOMICS,  INC.
                                   A  Nevada  Corporation

                                   By:___________________________
                                   Name:   Michael  Dent
                                   Title:     Chief  Executive  Officer

                                   NEOGENOMICS,  INC.
                                   A  Florida  Corporation

                                   By:___________________________
                                   Name:   Michael  Dent
                                   Title:     Chief  Executive  Officer

                                   The  Investor:

                                   ________________________________
                                   Larry  Kuhnert
                                   Address:
                                   5120  Timberview  Terrace
                                   Orlando,  FL  32819

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00052-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00052-of-00352.parquet"}]]